XML 74 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Aug. 29, 2015
Aug. 30, 2014
Operating activities:    
Net income $ 14,751 $ 5,650
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 7,302 5,428
Equity in undistributed income of investments and unconsolidated affiliated companies (220) $ (534)
Non-cash asset impairment charges 106
Non-cash portion of lease exit costs 419
Remeasurement gain on acquisition of affiliate (7,212)
Tenant improvement allowance received from lessors 933 $ 2,119
Deferred income taxes $ 3,778 882
Collateral deposited with insurance carrier (1,150)
Other, net $ 1,445 (165)
Changes in operating assets and liabilities:    
Accounts receivable (751) 19
Inventories (8,165) (1,151)
Other current assets (21) 732
Customer deposits (3,196) 3,870
Accounts payable and accrued liabilities 2,158 2,570
Net cash provided by operating activities 11,327 18,270
Investing activities:    
Purchases of property and equipment (11,283) (15,210)
Proceeds from sales of property and equipment 2,952 $ 5,157
Cash paid for business acquisition, net of cash acquired (7,323)
Capital contribution to affiliate $ (1,345)
Proceeds from maturity of short-term investments $ 5,000
Proceeds from sale of interest in affiliate 2,348
Other 246
Net cash used in investing activities $ (16,999) (2,459)
Financing activities:    
Cash dividends (4,806) (4,316)
Proceeds from the exercise of stock options 4,018 33
Other issuance of common stock 254 242
Repurchases of common stock (1,374) (4,621)
Taxes paid related to net share settlement of equity awards (178) (489)
Excess tax benefits from stock-based compensation 2,008 257
Repayments of notes payable (1,630) $ (208)
Proceeds from equipment loans 1,307
Net cash used in financing activities (401) $ (9,102)
Change in cash and cash equivalents (6,073) 6,709
Cash and cash equivalents - beginning of period 26,673 12,733
Cash and cash equivalents - end of period $ 20,600 $ 19,442